Cargando…

704 Ceftazidime / Avibactam Efficacy for Treating Carbapenem-resistant Infections in Critically Ill Patients with Thermal Injuries

INTRODUCTION: Rising antimicrobial resistance is a pressing public health concern. Emergence of carbapenem-resistant organisms has led to increased use of novel antibiotics, such as ceftazidime/avibactam (CZ/AV). However, recent studies have shown increasing treatment failures and resistance rates a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hill, David M, Martin, Kelsey, Arif, Faisal, Sultan-Ali, Ibrahim, Velamuri, Sai R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Clinical Sciences: Critical Care 3
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945950/ http://dx.doi.org/10.1093/jbcr/irac012.258

Ejemplares similares

516 Phosphorus Requirements in Patients with Severe Thermal Injuries Requiring High-Volume Hemofiltration
por: Hill, David M, et al.
Publicado: (2022)

515 Deficiencies of Rule-based Technology generated Antibiograms and Application in Patients with Prolonged Lengths of Stay
por: Hill, David M, et al.
Publicado: (2022)

Treatment of Carbapenem-Resistant Enterobacteriaceae Infections with Ceftazidime-Avibactam
por: Rahmati, Elham, et al.
Publicado: (2017)

Ceftazidime-Avibactam in Combination with In Vitro Non-susceptible Antimicrobials Versus Ceftazidime-Avibactam in Monotherapy in Critically Ill Patients with Carbapenem-Resistant Klebsiella Pneumoniae Infection: A Retrospective Cohort Study
por: Zheng, Guanhao, et al.
Publicado: (2021)

CLINICAL CHARACTERISTICS OF CRITICALLY ILL YOUNG ADULT PATIENTS
por: Martell, Sarah, et al.
Publicado: (2020)

Correction to: Ceftazidime-Avibactam in Combination with In Vitro Non-susceptible Antimicrobials Versus Ceftazidime-Avibactam in Monotherapy in Critically Ill Patients with Carbapenem-Resistant Klebsiella Pneumoniae Infection: A Retrospective Cohort Study
por: Zheng, Guanhao, et al.
Publicado: (2022)

704 Extubation Success in Pediatric Burn Patients with Neuromuscular Blockade: A 10-year review
por: Pierzchajlo, Noah, et al.
Publicado: (2023)

Ceftazidime-avibactam
por: Matesanz, Mayra, et al.
Publicado: (2021)

Ceftazidime-avibactam
por: Herrero, Francisco Sanz
Publicado: (2022)

Efficacy of ceftazidime-avibactam in the treatment of infections due to Carbapenem-resistant Enterobacteriaceae
por: Alraddadi, Basem M., et al.
Publicado: (2019)

621. In vitro Ceftazidime: Avibactam Resistance in Carbapenem-Resistant Enterobacteriaceae Isolates
por: Belal, Maymonah, et al.
Publicado: (2019)

Ceftazidime-Avibactam Therapy Versus Ceftazidime-Avibactam-Based Combination Therapy in Patients With Carbapenem-Resistant Gram-Negative Pathogens: A Meta-Analysis
por: Li, Dan, et al.
Publicado: (2021)

EFFECTS OF THE COVID-19 PANDEMIC ON SEDATION PRACTICES AND ABCDEF BUNDLE COMPLIANCE: A NATIONAL SURVEY OF INTENSIVISTS IN THE UNITED STATES
por: BRAUN, A., et al.
Publicado: (2022)

BAROTRAUMA IN CRITICALLY ILL PATIENTS WITH COVID-19
por: MURAG, SOUMYA, et al.
Publicado: (2021)

Ceftazidime–Avibactam-Based Versus Tigecycline-Based Regimen for the Treatment of Carbapenem-Resistant Klebsiella pneumoniae-Induced Pneumonia in Critically Ill Patients
por: Shi, Ying, et al.
Publicado: (2021)

In Vitro Activity Comparison of Ceftazidime–Avibactam and Aztreonam–Avibactam Against Bloodstream Infections With Carbapenem-Resistant Organisms in China
por: Yu, Wei, et al.
Publicado: (2021)

Clinical Outcome of Patients on Ceftazidime–Avibactam and Combination Therapy in Carbapenem-resistant Enterobacteriaceae
por: Nagvekar, Vasant, et al.
Publicado: (2021)

A Selective Medium for Screening Ceftazidime/Avibactam Resistance in Carbapenem-Resistant Enterobacterales
por: Zeng, Weiliang, et al.
Publicado: (2022)

VALIDATION OF SOFA SCORE IN CRITICALLY ILL PATIENTS WITH COVID-19
por: Martinez, Andres Chacon, et al.
Publicado: (2020)

ANTICOAGULATION, BLEEDING, AND IMMUNOTHROMBOSIS IN CRITICALLY ILL PATIENTS WITH COVID-19
por: PAEZ VARGAS, JUAN, et al.
Publicado: (2021)

FLIPPING THE CLASSROOM IN CRITICAL CARE: A NOVEL INTRODUCTION TO THE CRITICALLY ILL PATIENT FOR SENIOR MEDICAL STUDENTS
por: JAMES, RYAN, et al.
Publicado: (2021)

VENTILATOR MECHANICS AND OUTCOMES IN CRITICALLY ILL PATIENTS WITH COVID-19 INFECTION
por: Chaudhary, Siddique, et al.
Publicado: (2020)

Ceftazidime-Avibactam Combination Therapy Compared to Ceftazidime-Avibactam Monotherapy for the Treatment of Severe Infections Due to Carbapenem-Resistant Pathogens: A Systematic Review and Network Meta-Analysis
por: Fiore, Marco, et al.
Publicado: (2020)

Ceftazidime/avibactam for specified infections
Publicado: (2020)

Ceftazidime/Avibactam versus Polymyxin B in the Challenge of Carbapenem-Resistant Pseudomonas aeruginosa Infection
por: Chen, Juan, et al.
Publicado: (2022)

Ceftazidime/Avibactam for the Treatment of Carbapenem-Resistant Pseudomonas aeruginosa Infection in Lung Transplant Recipients
por: Chen, Juan, et al.
Publicado: (2023)

In Vitro Susceptibility to Ceftazidime-Avibactam and Comparator Antimicrobial Agents of Carbapenem-Resistant Enterobacterales Isolates
por: Lim, Tze-Peng, et al.
Publicado: (2023)

Cost-effectiveness analysis of ceftazidime avibactam versus colistin in carbapenem-resistant enterobacteriaceae in Iran
por: Goudarzi, Zahra, et al.
Publicado: (2023)

PNEUMOMEDIASTINUM IN A CRITICALLY ILL CORONAVIRUS DISEASE 2019 (COVID-19) PATIENT
por: Hayrabedian, Moses, et al.
Publicado: (2020)

CONVALESCENT PLASMA THERAPY IN CRITICALLY ILL PATIENTS WITH LATE STAGE COVID-19
por: Kumar, Neil, et al.
Publicado: (2020)

COVID-19 is associated with distinct myopathic features in the diaphragm of critically ill patients
por: Shi, Zhonghua, et al.
Publicado: (2021)

PROLONGED DEXAMEMETHASONE LEADING TO ALDOSTERONE SUPPRESSION IN CRITICALLY ILL PATIENT WITH COVID-19
por: SINGH, KARAN, et al.
Publicado: (2021)

1422. Comparative Monte-Carlo Analysis of Aztreonam-Avibactam vs. Ceftazidime–Avibactam Against Carbapenem-Resistant Gram-Negative Pathogens
por: Smith, Aaron, et al.
Publicado: (2018)

In Vitro Activities and Inoculum Effects of Ceftazidime-Avibactam and Aztreonam-Avibactam against Carbapenem-Resistant Enterobacterales Isolates from South Korea
por: Kim, Taeeun, et al.
Publicado: (2020)

Antibacterial Activity and Optimal Treatment of Ceftazidime-Avibactam and Aztreonam-Avibactam Against Bloodstream Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae
por: Yu, Wei, et al.
Publicado: (2021)

Physical rehabilitation interventions for adult patients during critical illness: an overview of systematic reviews
por: Connolly, Bronwen, et al.
Publicado: (2016)

Randomised controlled trial of GM-CSF in critically ill patients with impaired neutrophil phagocytosis
por: Pinder, Emma M, et al.
Publicado: (2018)

Frailty and outcomes from pneumonia in critical illness: a population-based cohort study
por: Darvall, Jai N., et al.
Publicado: (2020)

A CASE OF BOWEL PERFORATION IN A CRITICALLY ILL PATIENT ADMITTED WITH SARS-COV2
por: Parhar, Gaurav, et al.
Publicado: (2020)

Mucoactive agents for acute respiratory failure in the critically ill: a systematic review and meta-analysis
por: Anand, Rohan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jk3q5ju0d3sfvnu0shget1pl99